Posted on

New Study Links Popular Weight-Loss and Diabetes Medications to Lower Cancer Risk

A recent study published in JAMA Network Open reveals that GLP-1 medications, including popular drugs like Ozempic and Wegovy, may significantly reduce the risk of certain cancers in individuals with type 2 diabetes. The study, conducted by researchers from Case Western Reserve University School of Medicine and the MetroHealth System, analyzed over a decade’s worth of medical records from nearly 1.7 million people.

Key Findings:

  • Reduction in Cancer Risk: The study found that individuals treated with GLP-1 drugs were significantly less likely to be diagnosed with 10 out of 13 obesity-associated cancers compared to those treated with insulin. Notably, the risk of gallbladder cancer, meningioma, pancreatic cancer, and hepatocellular carcinoma (a type of liver cancer) was reduced by more than half.
  • Broader Implications: The findings suggest a significant reduction in risk for ovarian cancer, colorectal cancer, multiple myeloma, esophageal cancer, endometrial cancer, and kidney cancer among those on GLP-1 treatment.
  • Weight and Cancer Connection: Excess weight is known to increase the risk of 13 types of cancer, contributing to about 40% of new cancer diagnoses in the U.S. annually. Overweight individuals often experience long-lasting inflammation and elevated levels of insulin and sex hormones, which can contribute to cancer development.

Comparative Insights:

  • Other Treatments: The cancer risk reduction observed with GLP-1 medications compares favorably to the benefits seen with intensive lifestyle changes and metabolic-bariatric surgery, highlighting the potential of these drugs beyond their primary use.

Exceptions and Cautions:

  • No Impact on Certain Cancers: The study noted that GLP-1 treatment did not reduce the risk of postmenopausal breast cancer, stomach cancer, or thyroid cancer. In fact, some research indicates potential negative effects on the thyroid.
  • Comparison with Metformin: The study found no significant difference in overall cancer diagnosis risk between those treated with GLP-1s and those treated with metformin, although a higher risk of kidney cancer was noted in the GLP-1 group.

Conclusion and Future Directions:

While more research is needed to understand the relationship between weight loss and reduced cancer risk, the study provides preliminary evidence supporting the potential cancer-preventive benefits of GLP-1 receptor agonists in high-risk populations. The authors call for further preclinical and clinical studies to explore these findings in greater detail.

This study underscores the growing understanding of how GLP-1 medications might play a role in cancer prevention, offering hope for new strategies in managing cancer risk among individuals with type 2 diabetes and obesity.

วิสกัส อาหารแมว ชนิดแห้ง แบบเม็ด พ็อกเกต สูตรแมวโต รสปลาทู 3 กก

เข้าดูโปรโมชั่น

Posted on Leave a comment

Experts Raise Concerns About Weight Loss Medications and Eating Disorders

Experts are expressing growing concerns regarding the use of popular weight loss medications and their potential impact on individuals with eating disorders, citing a lack of comprehensive research and potential consequences.

The medication in question, semaglutide, commonly known by brand names such as Ozempic and Wegovy, initially prescribed for diabetes management, is increasingly being utilized for weight loss purposes. However, as its availability rises, experts are apprehensive about its effects on individuals with eating disorders.

One crucial concern raised is the potential for weight loss medications to reignite or exacerbate eating disorder behaviors, particularly among individuals with a history of such conditions. Anecdotal evidence suggests that individuals in remission from eating disorders may experience relapses after initiating treatment with GLP-1 agonists.

Furthermore, the physiological effects of appetite suppression from these medications can disrupt natural hunger cues, leading to disordered eating patterns and psychological distress. Experts stress the importance of vigilant screening by healthcare providers and regular monitoring of individuals’ mental and physical well-being.

For those grappling with eating disorders or susceptible to their development, seeking support from healthcare professionals and accessing resources for education and assistance is paramount. Addressing concerns surrounding weight loss medications and their potential impact on eating disorders requires a multifaceted approach encompassing research, healthcare provider education, and public awareness.

Posted on

New Study Reveals Potential for Weight Loss Treatments to Combat Obesity Epidemic

A groundbreaking study published in JAMA Network Open Journal sheds light on the efficacy of weight management treatments (WMT) in combating obesity among primary care patients. The research, titled “Weight Loss Treatment and Longitudinal Weight Change Among Primary Care Patients With Obesity,” analyzed data from 146,959 participants and uncovered significant findings regarding the impact of WMT on weight loss.

Key Findings:

  • Low Utilization, High Potential: Only 7.1% of primary care patients with obesity utilized WMT in 2019, highlighting low utilization rates.
  • Effectiveness of WMT: The study revealed that WMT can significantly support 5% or greater weight loss for individual patients. The effectiveness varied depending on the type of treatment, with nutrition counseling showing a 1-year probability of 5% or greater weight loss at 23.1%, while bariatric surgery showed a striking 93.0% probability.
  • Population-Level Impact: Despite the effectiveness of WMT at the individual level, low utilization rates limit their population-level potential. However, the study suggests that increasing WMT utilization could lead to significant population-wide weight loss.

Implications and Recommendations:

  • Urgent Need for Action: With obesity rates projected to continue rising, there is an urgent need to address this public health issue. The study underscores the importance of implementing strategies to increase the utilization of effective weight management treatments.
  • Health System Interventions: Health systems and insurers are urged to consider novel strategies to enhance the use of WMT among individuals and populations with obesity. This may include promoting awareness, improving accessibility, and reducing barriers to treatment.
  • Policy Considerations: Policymakers should prioritize initiatives aimed at supporting weight management interventions, including measures to improve coverage and affordability of treatments.
  • Future Research: Further research is needed to explore additional weight management treatments and their potential impact on weight loss at both the individual and population levels.

Conclusion: The findings of this study provide valuable insights into the role of weight management treatments in combating obesity. By increasing the utilization of effective treatments, there is potential to make significant strides in reducing obesity rates and improving public health outcomes. This underscores the importance of collective efforts from healthcare providers, policymakers, and individuals in tackling the obesity epidemic.

Credit: JAMA Network Open Journal, James Henderson, Anne P. Ehlers, Joyce M. Lee

Posted on

Global Study Reveals Alarming Rates of Teens Using Risky Weight-Loss Products

A comprehensive global analysis has unveiled that approximately 9% of teenagers worldwide, with a significant focus on girls, have resorted to non-prescribed drugs, dietary supplements, and other weight-loss products, posing serious threats to their physical and mental well-being.

The study, which examined numerous research findings spanning four decades, estimates that half of these adolescents have used over-the-counter weight-loss products in the past month. Disturbingly, diet pills emerged as the most commonly used products, accounting for 6% of adolescent usage, followed by 4% using laxatives and 2% using diuretics.

These practices are not only medically unsupported for maintaining healthy weight but also linked to severe consequences for children’s health. Previous research has associated the use of such non-prescribed products with eating disorders, low self-esteem, depression, and substance abuse among teens. Moreover, they have been correlated with poor nutritional intake during adolescence and unhealthy weight gain in adulthood.

Dr. Paula Cody, the medical director of adolescent medicine at the University of Wisconsin School of Medicine and Public Health, expressed heightened concerns regarding the increasing use of diet pills and supplements, especially among teens. She warned about their dangers over six years ago, and with the surge in eating disorders post-pandemic, her concerns have only intensified.

The study’s findings also highlighted a significant increase in hospital admissions for eating disorders among children in the United States during the first year of the Covid-19 pandemic. The prevalence of such weight-loss product usage was noted across multiple countries, with North America having the highest occurrence.

Dr. Cody emphasized the drastic impact of these products on patients, with changes in heart rate, blood pressure, and sleep patterns being observed. In some cases, patients can stop using the pills after understanding the health risks, but for others struggling with eating disorders, the allure of achieving a lower number on the scale may outweigh their health concerns.

Childhood obesity remains a global concern, affecting approximately 39 million children in 2022 according to the World Health Organization. In the U.S., childhood obesity is labeled a “serious problem” by the Centers for Disease Control and Prevention, affecting nearly one in five children aged 2 to 17.

While formal weight-loss programs within the healthcare system aim to mitigate risks, adolescents often turn to unregulated products, leading to more problematic mental and eating behaviors. Dr. Sarah Raatz, a pediatrician with the University of Minnesota’s Center for Pediatric Obesity Medicine, stressed the importance of structured programs and guidance to safeguard against these risks.

The researchers of the study have called for urgent interventions to prevent and regulate the use of weight-loss products among teens, expressing deep concern about how easily accessible these products are to the adolescent population.

Posted on

Time-Restricted Eating Proves Effective for Weight Loss in Type 2 Diabetes Patients

In a groundbreaking study, researchers have discovered that time-restricted eating (TRE) offers a more effective approach to weight loss in adults with Type 2 diabetes (T2D) compared to daily calorie restriction (CR). The study, conducted as a 6-month randomized clinical trial at the University of Illinois Chicago, involved 75 participants with obesity and T2D.

The primary question addressed in this study was whether TRE, which restricts eating to a specific time window without calorie counting, is more effective for weight reduction and glycemic control than daily calorie restriction or a control condition in adults with T2D.

Here are the key findings:

  • TRE was significantly more effective for weight loss (with a 3.6% reduction) compared to CR (with a 1.8% reduction) in contrast to the control group.
  • However, changes in hemoglobin A1c (HbA1c) levels did not significantly differ between the TRE and CR groups compared to the control group.
  • TRE, which involves an 8-hour eating window from 12 PM to 8 PM without calorie counting, proved to be an attractive and effective alternative to CR for weight loss in patients with T2D.

This study addresses the critical need for innovative lifestyle strategies to treat T2D as the prevalence of this disease continues to rise in the United States. Calorie restriction is a commonly recommended method for managing T2D, but many patients struggle to adhere to it because it necessitates constant monitoring of calorie intake.

Time-restricted eating is emerging as a more palatable and potentially effective alternative. It restricts daily food intake to a specific time window, naturally reducing calorie consumption, which in turn helps with weight loss.

While this research demonstrates promising results for TRE, it should be noted that further studies with larger sample sizes and longer durations are needed to confirm these findings. The study’s participants found the TRE regimen easier to follow than daily calorie counting, which suggests that it could be a valuable tool in the battle against obesity and T2D.

With approximately one in ten U.S. residents living with Type 2 diabetes, these findings represent a significant step forward in providing effective and accessible treatment strategies for this widespread condition.

Source: JAMA Network Open Journal

Posted on Leave a comment

Exercising Between 7 a.m. and 9 a.m. Proven as Optimal Time for Weight Loss, New Study Reveals

Research Highlights Morning Workouts’ Impact on Waist Circumference and BMI

In the pursuit of effective weight loss strategies, the timing of your exercise routine may be the key to success, according to a groundbreaking study published in the journal Obesity. The research, involving a significant sample of 5,285 participants, discovered that individuals who engage in physical activity between 7 a.m. and 9 a.m. experience more substantial weight loss, as measured by their waist circumference and body mass index (BMI), compared to those exercising during midday or evening.

Clinical psychologist Rebecca Krukowski, a specialist in behavioral weight management, commented on the study’s significance, emphasizing the importance of scheduling exercise in the morning to minimize distractions from emails, phone calls, or meetings that can derail fitness goals.

While prior research has identified a connection between moderate-to-vigorous physical activity and weight loss, determining the most effective time for exercise has yielded mixed results. To address this gap, the researchers examined data from participants in the 2003 to 2006 cycles of the US Center for Disease Control and Prevention’s National Health and Nutrition Examination Survey.

Participants wore activity trackers for extended periods during the day and had their BMI and waist circumference recorded. The study found that those who exercised in the morning, between 7 a.m. and 9 a.m., boasted an average BMI of 27.5, while midday and evening exercisers had an average BMI of 28.3. This difference was consistent even when accounting for factors like diet quality, calorie intake, sex, ethnicity, education, tobacco use, alcohol consumption, or sedentary behavior.

Remarkably, the benefits of morning exercise remained significant among individuals who met the recommended 150 minutes of physical activity per week. The research demonstrated that morning exercise is linked to the lowest BMI and waist size.

However, the study did not measure BMI and waist size after the activity tracking period, making it challenging to establish a direct causal relationship between morning exercise and the observed reductions in these measurements. The lead author, Dr. Tongyu Ma, plans to conduct further studies to confirm these findings and explore potential causal connections.

The factors driving these findings may stem from both physiology and lifestyle habits. People who consistently exercise in the morning may have more predictable schedules, which could have additional positive effects on weight related to sleep quality and stress levels. Additionally, morning exercisers appear to have a lower daily caloric intake and higher passive energy expenditure, likely due to exercising in a fasted state.

Notably, the study found that morning exercisers had the lowest BMI and waist circumference, even though they were the most sedentary post-exercise. This suggests that morning workouts may set the stage for enhanced fat oxidation, potentially contributing to greater weight loss throughout the day.

Furthermore, the study observed that morning exercisers tended to adopt more structured and concentrated exercise routines, contributing to their superior weight loss results. Dr. Tongyu Ma emphasized that early morning aerobic exercises like biking, running, or brisk walking show promise as effective tools for weight loss, as people are generally more likely to adhere to a morning workout routine.

Posted on Leave a comment

Coffee and Weight Loss: A Complex Relationship Explored by Registered Dietitians

Registered dietitians weigh in on whether coffee aids or hinders weight loss, offering insights and recommendations.

Coffee, in its various forms and flavors, is a beloved daily ritual for many. However, the question of whether coffee supports or hinders weight loss has generated widespread discussion. In this article, we delve into the insights provided by registered dietitians, shedding light on the multifaceted relationship between coffee consumption and weight management.

Mixed Perspectives within the Scientific Community: The impact of coffee on weight loss remains a topic of debate even within the scientific community. Amy Gorin, RDN, a registered dietitian nutritionist, cautions against increasing coffee or caffeine intake solely for weight loss purposes. While coffee is generally acceptable in moderation, individuals with heart conditions should exercise caution due to caffeine’s potential to elevate blood pressure.

Coffee’s Effect on Weight Loss: A Complex Picture: Scientific studies have provided mixed findings regarding coffee’s role in weight loss. Some studies suggest potential benefits:

  1. Caffeine’s Impact on Brown Adipose Tissue: A 2019 study in Scientific Reports found that coffee consumption may stimulate brown adipose tissue, which burns calories, potentially leading to weight loss.
  2. Metabolic Boost from Caffeine: Harvard researchers reported in 2020 that individuals who consumed four cups of caffeinated coffee daily experienced a four percent reduction in body fat. This effect is attributed to coffee’s ability to raise metabolic rates, resulting in increased calorie expenditure.
  3. Caffeinated Mate Tea Extract: A 2020 study on rats, published in the Journal of Functional Foods, found that caffeinated mate tea extract reduced the incidence of weight gain and body fat accumulation, which was not observed with decaffeinated extract.

However, some studies indicate potential drawbacks of coffee consumption:

  1. Association with Higher BMI: A 2021 study published in the Food & Function journal linked increased consumption of caffeinated beverages, including coffee, to higher body mass index (BMI).
  2. Sugar Cravings: Drinking caffeinated coffee has been associated with heightened sugar cravings, potentially leading to unhealthy snack choices and impeding weight loss efforts.
  3. Sleep Disturbances: A 2013 study published in the Journal of Clinical Sleep Medicine found that consuming coffee up to six hours before bedtime can disrupt sleep patterns, with poor or insufficient sleep repeatedly linked to weight gain.

Balanced Coffee Consumption: The consensus among registered dietitians is that moderate coffee consumption, generally staying below 400 milligrams of caffeine daily, is acceptable. The timing of coffee consumption is crucial to avoid disrupting sleep patterns. Registered dietitian Monica L Capille recommends having the last cup of coffee before 2:00 p.m.

Pairing coffee with a balanced breakfast that includes protein, whole grains, healthy fats, fruits, and vegetables is advised. This approach ensures that the body receives necessary nutrients and energy while minimizing muscle loss during weight loss efforts.

Mindful Coffee Additives: When it comes to coffee additives, experts advise caution. Excessive use of cream and sugar can negate coffee’s anti-inflammatory and antioxidant benefits, potentially derailing weight loss goals. Healthier alternatives include sugar-free syrups and sugar substitutes.

Coffee Supplements: An Uncertain Path: Green coffee bean extract supplements, often promoted as natural weight-loss aids, are derived from unroasted coffee beans and contain higher levels of chlorogenic acids. While preliminary research suggests a connection between these supplements and weight loss, more comprehensive studies are needed. Caution is advised due to their caffeine content and the lack of FDA regulation in the supplement industry.

Decaf Coffee’s Role: Even decaffeinated coffee contains trace amounts of caffeine, making it unsuitable for those strictly avoiding caffeine. However, for individuals on a low-caffeine diet, decaf coffee might provide some health benefits, although its impact on weight loss remains uncertain.

Conclusion: In summary, the relationship between coffee and weight loss is multifaceted, with mixed findings from scientific studies. While coffee can be enjoyed in moderation as part of a healthy lifestyle, it should not be relied upon as a primary tool for weight loss. Individual preferences and tolerances should guide coffee consumption, with an emphasis on balanced nutrition and mindful additives. Further research is needed to provide a clearer understanding of coffee’s role in weight management.